Coagulation activation is primarily driven by the TF pathway, and, interference with the TF pathway consistently reduces coagulopathy, both in studies of systemic infection and in studies of local infection, like pneumonia [5, 6, 9, 10, 12, 14, 29–36]. Here, TF is linked to blood coagulation disease.